Amarin is a global pharmaceutical company committed to providing cost-effective cardiovascular care to high-risk adult cardiovascular patients. Find out more.
Committed to reducing the cardiovascular disease burden for patients and communities and to advancing the science of cardiovascular care around the world.
Amarin strives to ensure that our stakeholders have access to appropriate information about our financial growth.
Event Details
Amarin Corporation’s Fourth Quarter & Full Year 2025 Results
You have selected a link that will take you away from the amarincorp.com website. Amarin is not responsible for the content of the alternate website. Privacy and security policies of the alternate website may differ from those practiced by Amarin.
By clicking on the continue button below, you acknowledge the previous statement and will be taken to the linked site. If you want to remain at this site, select the cancel button. Thank you.